skip to main content
Idioma:
Refinado por: Nome da Publicação: Nuclear medicine communications remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
First-pass scintigraphy with (99m)Tc macroaggregated albumin a method for evaluating pulmonary arterial flow pulsatility
First-pass scintigraphy with (99m)Tc macroaggregated albumin a method for evaluating pulmonary arterial flow pulsatility
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-pass scintigraphy with (99m)Tc macroaggregated albumin a method for evaluating pulmonary arterial flow pulsatility

Marcelo T. Sapienza Carla R Ono; Tomoco Watanabe; Carlos A Buchpiguel; Fausto H Hironaka

Nuclear Medicine Communications London v. 25, n. 6, p. 571-576, 2004

London 2004

Localização: FM - Fac. Medicina    (BCSEP 297 2004 )(Acessar)

2
First-pass scintigraphy with (99m)Tc macroaggregated albumin a method for evaluating pulmonary arterial flow pulsatility
First-pass scintigraphy with (99m)Tc macroaggregated albumin a method for evaluating pulmonary arterial flow pulsatility
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-pass scintigraphy with (99m)Tc macroaggregated albumin a method for evaluating pulmonary arterial flow pulsatility

Marcelo T. Sapienza Carla R Ono; Tomoco Watanabe; Carlos A Buchpiguel; Fausto H Hironaka

Nuclear Medicine Communications London v. 25, n. 6, p. 571-576, 2004

London 2004

Localização: FM - Fac. Medicina    (BCSEP 297 2004 )(Acessar)

3
Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?

José Willegaignon de Amorim de Carvalho Marcelo Sapienza; Carla Ono; Tomoco Watanabe; Maria Inês Guimarães; Ricardo Gutterres; Maria Helena Marechal; Carlos Buchpiguel

Nuclear Medicine Communications London 30, n. 7, p. 533-541, 2009

London 2009

Localização: FM - Fac. Medicina    (BCSEP 188 2009 )(Acessar)

4
Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?

José Willegaignon de Amorim de Carvalho Marcelo Sapienza; Carla Ono; Tomoco Watanabe; Maria Inês Guimarães; Ricardo Gutterres; Maria Helena Marechal; Carlos Buchpiguel

Nuclear Medicine Communications London 30, n. 7, p. 533-541, 2009

London 2009

Localização: FM - Fac. Medicina    (BCSEP 188 2009 )(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.